{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:42:27Z","timestamp":1794649347852,"version":"4.9.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82405364"],"award-info":[{"award-number":["82405364"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Development Plan Project of Jilin Province","award":["20210304001YY"],"award-info":[{"award-number":["20210304001YY"]}]},{"name":"Innovation and Entrepreneurship Talent Funding Project of Jilin Province","award":["2022ZY10"],"award-info":[{"award-number":["2022ZY10"]}]},{"name":"Cultivation Project of Young Discipline Backbone Talent","award":["202320"],"award-info":[{"award-number":["202320"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetic kidney disease (DKD) is a microangiopathic complication of diabetes. Yiqi Wenyang Formula (YQWYF) has been used to treat DKD in the clinic for many years. However, the underlying regulatory mechanisms of YQWYF on the gut microbiota and bile acids of DKD mice remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose of the research<\/jats:title>\n                    <jats:p>This study aimed to investigate the mechanism of YQWYF on DKD mice using an integrative approach of network pharmacology, fecal 16S ribosomal RNA (rRNA) gene sequencing, and untargeted metabolomics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The chemical composition of YQWYF was determined via ultrahigh-performance liquid chromatography\/quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF\/MS). Common targets were identified between YQWYF and DKD, and a potential protein\u2013protein interaction (PPI) network was constructed using network pharmacology. DKD mice were induced with streptozotocin (STZ) for 18\u00a0weeks. Twenty-four-hour urine was collected on the 9th and 18th weeks, and serum was collected on the 18th week to detect the biochemical measurements of urine and serum. Oxidative stress biomarkers and inflammatory cytokines in the kidney were detected via ELISA kits. The microstructure of the renal tissue was assessed by hematoxylin\u2013eosin staining, periodic-acid Schiff staining, and Masson staining. Fresh fecal sample of mice were collected on the 18th week to detect the gut metabolites and microbiota using untargeted metabolomics and 16S rRNA sequencing. We analyzed the gut microbiota-bile acid (BA) axis for mechanism exploration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 41 compounds were recognized in YQWYF. TNF and IL6 were the important core targets between YQWYF and DKD. The results of molecular docking revealed that astragaloside I, 16-meprednisone acetate, and astragaloside IV from YQWYF had strong affinities for TNF-\u03b1 and IL-6. Animal experiments showed that YQWYF reduced glycemia and improved lipid metabolism abnormalities in DKD mice. Moreover, it had excellent anti-oxidant and anti-inflammatory effects to ameliorate renal injury in DKD mice. YQWYF improved the richness and evenness of the gut microbiota and increased bile acid levels in the feces of DKD mice. Importantly, 4 genus bacteria (\n                      <jats:italic>christensenellaceae_R-7_group<\/jats:italic>\n                      ,\n                      <jats:italic>oscillibacter<\/jats:italic>\n                      ,\n                      <jats:italic>UCG-005<\/jats:italic>\n                      , and\n                      <jats:italic>[Eubacerium]_ xylanophilum_group<\/jats:italic>\n                      ) were closely related with 3 BAs (CA, GCA and DHCA). Meanwhile, YQWYF improved the protein expression of Farnesoid X receptor (FXR), CYP7A1 and CYP8B in the liver.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings reveal that YQWYF ameliorates renal injury in DKD mice by inhibiting the inflammatory, increasing the FXR signaling, and regulating the gut microbiota disorder and bile acid dysregulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-025-01238-3","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:20:36Z","timestamp":1761816036000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Yiqi Wenyang Formula ameliorates diabetic kidney disease via inhibiting inflammation and regulating the gut microbiota-bile acid axis in mice by FXR signaling pathway"],"prefix":"10.1186","volume":"20","author":[{"given":"Tongyi","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuguo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianze","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zepeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"issue":"10225","key":"1238_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/s0140-6736(20)30045-3","volume":"395","author":"B Boris","year":"2020","unstructured":"Boris B, Carrie P, Andrew SL, Mari S, Amir A, Molla A, et al. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709\u201333. https:\/\/doi.org\/10.1016\/s0140-6736(20)30045-3.","journal-title":"Lancet"},{"issue":"2","key":"1238_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.kint.2022.05.012","volume":"102","author":"KR Tuttle","year":"2022","unstructured":"Tuttle KR, Agarwal R, Alpers CE, Bakris GL, Brosius FC, Kolkhof P, et al. Molecular mechanisms and therapeutic targets for diabetic kidney disease. Kidney Int. 2022;102(2):248\u201360. https:\/\/doi.org\/10.1016\/j.kint.2022.05.012.","journal-title":"Kidney Int"},{"issue":"1","key":"1238_CR3","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41392-023-01400-z","volume":"8","author":"Y Li","year":"2023","unstructured":"Li Y, Liu Y, Liu S, Gao M, Wang W, Chen K, et al. Diabetic vascular diseases: molecular mechanisms and therapeutic strategies. Signal Transduct Target Ther. 2023;8(1):152. https:\/\/doi.org\/10.1038\/s41392-023-01400-z.","journal-title":"Signal Transduct Target Ther"},{"key":"1238_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119364","volume":"342","author":"Y Peng","year":"2025","unstructured":"Peng Y, Wu S, Xu Y, Ye X, Huang X, Gao L, et al. Huangqi-Danshen decoction alleviates renal fibrosis through targeting SCD1 to modulate cGAS\/STING signaling. J Ethnopharmacol. 2025;342:119364. https:\/\/doi.org\/10.1016\/j.jep.2025.119364.","journal-title":"J Ethnopharmacol"},{"key":"1238_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.917975","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Feng Y, Li M, Yang M, Shi G, Xuan Z, et al. Traditional Chinese Medicine in the treatment of chronic kidney diseases: theories, applications, and mechanisms. Front Pharmacol. 2022;13:917975. https:\/\/doi.org\/10.3389\/fphar.2022.917975.","journal-title":"Front Pharmacol"},{"key":"1238_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.594308","volume":"12","author":"D Jin","year":"2021","unstructured":"Jin D, Zhang Y, Zhang Y, Huang W, Meng X, Yang F, et al. Efficacy and safety of TangWang prescription for type 2 non-proliferative diabetic retinopathy: a study protocol for a randomized controlled trial. Front Pharmacol. 2021;12:594308. https:\/\/doi.org\/10.3389\/fphar.2021.594308.","journal-title":"Front Pharmacol"},{"issue":"2","key":"1238_CR7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.13935\/j.cnki.sjzx.220230","volume":"17","author":"H Lin","year":"2022","unstructured":"Lin H, Liu Y, Zhang G. Efficacy of Yiqi Wenyang Huoxue Tongluo prescription combined with acupuncture on type 2 diabetic perioheral neuropathy of Qi degiciency and blood stasis and its effect on oxidative stress. World J Integr Tradit Western Med. 2022;17(2):354\u20138. https:\/\/doi.org\/10.13935\/j.cnki.sjzx.220230.","journal-title":"World J Integr Tradit Western Med"},{"issue":"9","key":"1238_CR8","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.13193\/j.archtcm.2003.09.97.dij.055","volume":"21","author":"J Di","year":"2003","unstructured":"Di J. Protective effect of Tangwangfang on oxidative damage in rats with diabetes retinopathy. Chinese Arch TCM. 2003;21(9):1507\u201331. https:\/\/doi.org\/10.13193\/j.archtcm.2003.09.97.dij.055.","journal-title":"Chinese Arch TCM."},{"issue":"1","key":"1238_CR9","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1080\/13880209.2021.1979051","volume":"59","author":"Y Wang","year":"2021","unstructured":"Wang Y, Xue B, Wang X, Wang Q, Liu E, Chen X. Pharmacokinetic study of Tangwang Mingmu granule for the management of diabetic retinopathy based on network pharmacology. Pharm Biol. 2021;59(1):1334\u201350. https:\/\/doi.org\/10.1080\/13880209.2021.1979051.","journal-title":"Pharm Biol"},{"issue":"9","key":"1238_CR10","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.2337\/dci23-0030","volume":"46","author":"SC Naaman","year":"2023","unstructured":"Naaman SC, Bakris GL. Diabetic nephropathy: update on pillars of therapy slowing progression. Diabetes Care. 2023;46(9):1574\u201386. https:\/\/doi.org\/10.2337\/dci23-0030.","journal-title":"Diabetes Care"},{"key":"1238_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112254","volume":"148","author":"S Di","year":"2022","unstructured":"Di S, An X, Pang B, Wang T, Wu H, Wang J, et al. Yiqi Tongluo Fang could preventive and delayed development and formation of diabetic retinopathy through antioxidant and anti-inflammatory effects. Biomed Pharmacother. 2022;148:112254. https:\/\/doi.org\/10.1016\/j.biopha.2021.112254.","journal-title":"Biomed Pharmacother"},{"key":"1238_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.850167","volume":"13","author":"B Du","year":"2022","unstructured":"Du B, Yin Y, Wang Y, Fu H, Sun H, Yue Z, et al. Calcium dobesilate efficiency in the treatment of diabetic kidney disease through suppressing MAPK and chemokine signaling pathways based on clinical evaluation and network pharmacology. Front Pharmacol. 2022;13:850167. https:\/\/doi.org\/10.3389\/fphar.2022.850167.","journal-title":"Front Pharmacol"},{"key":"1238_CR13","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.lfs.2019.02.023","volume":"221","author":"J Liu","year":"2019","unstructured":"Liu J, Li S, Sun D. Calcium dobesilate and micro-vascular diseases. Life Sci. 2019;221:348\u201353. https:\/\/doi.org\/10.1016\/j.lfs.2019.02.023.","journal-title":"Life Sci"},{"issue":"3","key":"1238_CR14","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1159\/000495491","volume":"51","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Qi C, Li S, Shao X, Mou S, Ni Z. Diabetic nephropathy can be treated with calcium dobesilate by alleviating the chronic inflammatory state and improving endothelial cell function. Cell Physiol Biochem. 2018;51(3):1119\u201333. https:\/\/doi.org\/10.1159\/000495491.","journal-title":"Cell Physiol Biochem"},{"issue":"50","key":"1238_CR15","doi-asserted-by":"publisher","first-page":"20372","DOI":"10.1021\/acs.jafc.3c04996","volume":"71","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Jiang M, Liu M, Wang H, Wang W, Zhang T, et al. Spatial distribution and characterization of the small-molecule metabolites and in situ hydrolyzed oligosaccharides in the rhizome of glycyrrhiza uralensis by desorption electrospray ionization-mass spectrometry imaging and high-resolution liquid chromatography-mass spectrometry. J Agric Food Chem. 2023;71(50):20372\u201385. https:\/\/doi.org\/10.1021\/acs.jafc.3c04996.","journal-title":"J Agric Food Chem"},{"key":"1238_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156138","volume":"135","author":"D Li","year":"2024","unstructured":"Li D, Chen R, Xu X, Hou Y, Li Z, Huang C, et al. Integrated metabolomics and network pharmacology to reveal the mechanisms of Shexiang Baoxin pill against atherosclerosis. Phytomedicine. 2024;135:156138. https:\/\/doi.org\/10.1016\/j.phymed.2024.156138.","journal-title":"Phytomedicine"},{"key":"1238_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156220","volume":"135","author":"L Wu","year":"2024","unstructured":"Wu L, Li L, Wang X, Wu H, Li M, Wang Y, et al. The inhibition of rutin on Src kinase blocks high glucose-induced EGFR\/ERK transactivation in diabetic nephropathy by integrative approach of network pharmacology and experimental verification. Phytomedicine. 2024;135:156220. https:\/\/doi.org\/10.1016\/j.phymed.2024.156220.","journal-title":"Phytomedicine"},{"key":"1238_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155368","volume":"128","author":"Z Wu","year":"2024","unstructured":"Wu Z, Shi R, Yan S, Zhang S, Lu B, Huang Z, et al. Integrating network pharmacology, experimental validation and molecular docking to reveal the alleviation of Yinhuang granule on idiopathic pulmonary fibrosis. Phytomedicine. 2024;128:155368. https:\/\/doi.org\/10.1016\/j.phymed.2024.155368.","journal-title":"Phytomedicine"},{"key":"1238_CR19","unstructured":"Bao Q. Gene verification of diabetic retinopathy and analysis of TangWangFang signaling pathway based on network pharmacology [J]. Guang'anmen Hospital, 2019, Master degree(SX16001): 44"},{"issue":"3","key":"1238_CR20","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008;22(3):659\u201361. https:\/\/doi.org\/10.1096\/fj.07-9574LSF.","journal-title":"FASEB J"},{"issue":"8","key":"1238_CR21","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1002\/ptr.7836","volume":"37","author":"H Zhang","year":"2023","unstructured":"Zhang H, Sun Y, Fan M, Zhang Y, Liang Z, Zhang L, et al. Prevention effect of total ginsenosides and ginseng extract from Panax ginseng on cyclophosphamide-induced immunosuppression in mice. Phytother Res. 2023;37(8):3583\u2013601. https:\/\/doi.org\/10.1002\/ptr.7836.","journal-title":"Phytother Res"},{"key":"1238_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.fsi.2024.109786","volume":"152","author":"K Zhao","year":"2024","unstructured":"Zhao K, Jia S, Wang J, Bian X, Chen S, Li J, et al. Effects of sand substrate removal on the intestinal antioxidant and metabolism in Marsupenaeus japonicus. Fish Shellfish Immunol. 2024;152:109786. https:\/\/doi.org\/10.1016\/j.fsi.2024.109786.","journal-title":"Fish Shellfish Immunol"},{"issue":"6","key":"1238_CR23","doi-asserted-by":"publisher","first-page":"401","DOI":"10.4155\/tde-2017-0010","volume":"8","author":"L Woodhams","year":"2017","unstructured":"Woodhams L, Al-Salami H. The roles of bile acids and applications of microencapsulation technology in treating type 1 diabetes mellitus. Ther Deliv. 2017;8(6):401\u20139. https:\/\/doi.org\/10.4155\/tde-2017-0010.","journal-title":"Ther Deliv"},{"key":"1238_CR24","doi-asserted-by":"publisher","first-page":"1680008","DOI":"10.1155\/2022\/1680008","volume":"2022","author":"R Sun","year":"2022","unstructured":"Sun R, Jiang J, Yang L, Chen L, Chen H. Alterations of serum bile acid profile in patients with crohn\u2019s disease. Gastroenterol Res Pract. 2022;2022:1680008. https:\/\/doi.org\/10.1155\/2022\/1680008.","journal-title":"Gastroenterol Res Pract"},{"issue":"8","key":"1238_CR25","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrd2619","volume":"7","author":"C Thomas","year":"2008","unstructured":"Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K. Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov. 2008;7(8):678\u201393. https:\/\/doi.org\/10.1038\/nrd2619.","journal-title":"Nat Rev Drug Discov"},{"key":"1238_CR26","doi-asserted-by":"publisher","first-page":"9966750","DOI":"10.1155\/2022\/9966750","volume":"2022","author":"M Chagas","year":"2022","unstructured":"Chagas M, Behrens MD, Moragas-Tellis CJ, Penedo GXM, Silva AR, Gon\u00e7alves-de-Albuquerque CF. Flavonols and flavones as potential anti-inflammatory, antioxidant, and antibacterial compounds. Oxid Med Cell Longev. 2022;2022:9966750. https:\/\/doi.org\/10.1155\/2022\/9966750.","journal-title":"Oxid Med Cell Longev"},{"issue":"33","key":"1238_CR27","doi-asserted-by":"publisher","first-page":"11640","DOI":"10.1080\/10408398.2022.2095349","volume":"63","author":"L Miao","year":"2023","unstructured":"Miao L, Liu C, Cheong MS, Zhong R, Tan Y, Rengasamy KRR, et al. Exploration of natural flavones\u2019 bioactivity and bioavailability in chronic inflammation induced-type-2 diabetes mellitus. Crit Rev Food Sci Nutr. 2023;63(33):11640\u201367. https:\/\/doi.org\/10.1080\/10408398.2022.2095349.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"11","key":"1238_CR28","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.3390\/molecules25112477","volume":"25","author":"M Sudhakaran","year":"2020","unstructured":"Sudhakaran M, Doseff AI. The targeted impact of flavones on obesity-induced inflammation and the potential synergistic role in cancer and the gut microbiota. Molecules. 2020;25(11):2477. https:\/\/doi.org\/10.3390\/molecules25112477.","journal-title":"Molecules"},{"key":"1238_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155196","volume":"123","author":"Y Shi","year":"2024","unstructured":"Shi Y, Shi X, Zhao M, Ma S, Zhang Y. Pharmacological potential of Astragali Radix for the treatment of kidney diseases. Phytomedicine. 2024;123:155196. https:\/\/doi.org\/10.1016\/j.phymed.2023.155196.","journal-title":"Phytomedicine"},{"issue":"6","key":"1238_CR30","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1142\/s0192415x24500708","volume":"52","author":"X Zhang","year":"2024","unstructured":"Zhang X, Wang J, Xiang S, Zhao L, Lv M, Duan Y, et al. Astragaloside I from Astragalus attenuates diabetic kidney disease by regulating HDAC3\/Klotho\/TGF-\u03b21 loop. Am J Chin Med. 2024;52(6):1795\u2013817. https:\/\/doi.org\/10.1142\/s0192415x24500708.","journal-title":"Am J Chin Med"},{"key":"1238_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.638422","volume":"12","author":"J Su","year":"2021","unstructured":"Su J, Gao C, Xie L, Fan Y, Shen Y, Huang Q, et al. Astragaloside II ameliorated podocyte injury and mitochondrial dysfunction in streptozotocin-induced diabetic rats. Front Pharmacol. 2021;12:638422. https:\/\/doi.org\/10.3389\/fphar.2021.638422.","journal-title":"Front Pharmacol"},{"key":"1238_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/bs.apha.2019.08.002","volume":"87","author":"J Zhang","year":"2020","unstructured":"Zhang J, Wu C, Gao L, Du G, Qin X. Astragaloside IV derived from Astragalus membranaceus: a research review on the pharmacological effects. Adv Pharmacol. 2020;87:89\u2013112. https:\/\/doi.org\/10.1016\/bs.apha.2019.08.002.","journal-title":"Adv Pharmacol"},{"key":"1238_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114598","volume":"163","author":"Y Gao","year":"2023","unstructured":"Gao Y, Su X, Xue T, Zhang N. The beneficial effects of astragaloside IV on ameliorating diabetic kidney disease. Biomed Pharmacother. 2023;163:114598. https:\/\/doi.org\/10.1016\/j.biopha.2023.114598.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1238_CR34","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1080\/13880209.2022.2067572","volume":"60","author":"D Huang","year":"2022","unstructured":"Huang D, Shen P, Wang C, Gao J, Ye C, Wu F. Calycosin plays a protective role in diabetic kidney disease through the regulation of ferroptosis. Pharm Biol. 2022;60(1):990\u20136. https:\/\/doi.org\/10.1080\/13880209.2022.2067572.","journal-title":"Pharm Biol"},{"issue":"11","key":"1238_CR35","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1021\/acs.jafc.5b05274","volume":"64","author":"ZQ Zhou","year":"2016","unstructured":"Zhou ZQ, Fan HX, He RR, Xiao J, Tsoi B, Lan KH, et al. Lycibarbarspermidines A-O, new dicaffeoylspermidine derivatives from Wolfberry, with activities against Alzheimer\u2019s disease and oxidation. J Agric Food Chem. 2016;64(11):2223\u201337. https:\/\/doi.org\/10.1021\/acs.jafc.5b05274.","journal-title":"J Agric Food Chem"},{"key":"1238_CR36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.phytochem.2019.04.017","volume":"164","author":"QW Li","year":"2019","unstructured":"Li QW, Zhang R, Zhou ZQ, Sun WY, Fan HX, Wang Y, et al. Phenylpropanoid glycosides from the fruit of Lycium barbarum L. and their bioactivity. Phytochemistry. 2019;164:60\u20136. https:\/\/doi.org\/10.1016\/j.phytochem.2019.04.017.","journal-title":"Phytochemistry"},{"issue":"4","key":"1238_CR37","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3945\/an.113.005603","volume":"5","author":"MA Alam","year":"2014","unstructured":"Alam MA, Subhan N, Rahman MM, Uddin SJ, Reza HM, Sarker SD. Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action. Adv Nutr. 2014;5(4):404\u201317. https:\/\/doi.org\/10.3945\/an.113.005603.","journal-title":"Adv Nutr"},{"key":"1238_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.946766","volume":"9","author":"Y He","year":"2022","unstructured":"He Y, Wang S, Sun H, Li Y, Feng J. Naringenin ameliorates myocardial injury in STZ-induced diabetic mice by reducing oxidative stress, inflammation and apoptosis via regulating the Nrf2 and NF-\u03baB signaling pathways. Front Cardiovasc Med. 2022;9:946766. https:\/\/doi.org\/10.3389\/fcvm.2022.946766.","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"1238_CR39","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4093\/dmj.2021.0329","volume":"46","author":"CY Jung","year":"2022","unstructured":"Jung CY, Yoo TH. Pathophysiologic mechanisms and potential biomarkers in diabetic kidney disease. Diabetes Metab J. 2022;46(2):181\u201397. https:\/\/doi.org\/10.4093\/dmj.2021.0329.","journal-title":"Diabetes Metab J"},{"issue":"12","key":"1238_CR40","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000006349","volume":"96","author":"H Chen","year":"2017","unstructured":"Chen H, Guo J, Zhao X, He X, He Z, Zhao L, et al. Retrospective analysis of the overt proteinuria diabetic kidney disease in the treatment of modified Shenzhuo formula for 2 years. Medicine. 2017;96(12):e6349. https:\/\/doi.org\/10.1097\/md.0000000000006349.","journal-title":"Medicine"},{"issue":"6","key":"1238_CR41","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.3390\/biomedicines11061527","volume":"11","author":"M Mogos","year":"2023","unstructured":"Mogos M, Socaciu C, Socaciu AI, Vlad A, Gadalean F, Bob F, et al. Metabolomic investigation of blood and urinary amino acids and derivatives in patients with type 2 diabetes mellitus and early diabetic kidney disease. Biomedicines. 2023;11(6):1527. https:\/\/doi.org\/10.3390\/biomedicines11061527.","journal-title":"Biomedicines"},{"key":"1238_CR42","doi-asserted-by":"publisher","first-page":"9893682","DOI":"10.1155\/2019\/9893682","volume":"2019","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Qi C, Li S, Shao X, Ni Z. Investigation of the mechanism underlying calcium dobesilate-mediated improvement of endothelial dysfunction and inflammation caused by high glucose. Mediators Inflamm. 2019;2019:9893682. https:\/\/doi.org\/10.1155\/2019\/9893682.","journal-title":"Mediators Inflamm"},{"key":"1238_CR43","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3389\/fphar.2019.00886","volume":"10","author":"Y Wang","year":"2019","unstructured":"Wang Y, Lu YH, Tang C, Xue M, Li XY, Chang YP, et al. Calcium dobesilate restores autophagy by inhibiting the VEGF\/PI3K\/AKT\/mTOR signaling pathway. Front Pharmacol. 2019;10:886. https:\/\/doi.org\/10.3389\/fphar.2019.00886.","journal-title":"Front Pharmacol"},{"issue":"5","key":"1238_CR44","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1080\/01616412.2022.2159109","volume":"45","author":"A Ozdemir","year":"2023","unstructured":"Ozdemir A, Ogden M, Kartal B, Ceylan AF, Yuksel U, Bakar B. Investigation of therapeutic effects of calcium dobesilate in cerebral hypoxia\/ reperfusion injury in rats. Neurol Res. 2023;45(5):472\u201387. https:\/\/doi.org\/10.1080\/01616412.2022.2159109.","journal-title":"Neurol Res"},{"issue":"5","key":"1238_CR45","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3969\/j.issn.1002-2406.2002.05.018","volume":"19","author":"L Zhao","year":"2002","unstructured":"Zhao L, Li L, Tang W, Li J. The researches on treatment of diabetic nephropathy with the therapy of supplementing qinourishing yin, warming yang, tonifying the kidney remoring blood stasis and resolring turbidity. Inf TCM. 2002;19(5):38\u20139. https:\/\/doi.org\/10.3969\/j.issn.1002-2406.2002.05.018.","journal-title":"Inf TCM"},{"issue":"5","key":"1238_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2023.108455","volume":"37","author":"SE Cifuentes-Mendiola","year":"2023","unstructured":"Cifuentes-Mendiola SE, Sol\u00eds-Suarez DL, Mart\u00ednez-Davalos A, Garc\u00eda-Hern\u00e1ndez AL. Macrovascular and microvascular type 2 diabetes complications are interrelated in a mouse model. J Diabetes Complications. 2023;37(5):108455. https:\/\/doi.org\/10.1016\/j.jdiacomp.2023.108455.","journal-title":"J Diabetes Complications"},{"key":"1238_CR47","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bbrc.2021.01.108","volume":"546","author":"JH Yun","year":"2021","unstructured":"Yun JH. Interleukin-1\u03b2 induces pericyte apoptosis via the NF-\u03baB pathway in diabetic retinopathy. Biochem Biophys Res Commun. 2021;546:46\u201353. https:\/\/doi.org\/10.1016\/j.bbrc.2021.01.108.","journal-title":"Biochem Biophys Res Commun"},{"issue":"Pt 3","key":"1238_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118957","volume":"337","author":"Y Tao","year":"2025","unstructured":"Tao Y, Zeng Y, Zeng R, Gou X, Zhou X, Zhang J, et al. The total alkaloids of Berberidis Cortex alleviate type 2 diabetes mellitus by regulating gut microbiota, inflammation and liver gluconeogenesis. J Ethnopharmacol. 2025;337(Pt 3):118957. https:\/\/doi.org\/10.1016\/j.jep.2024.118957.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"1238_CR49","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s12192-020-01170-5","volume":"26","author":"M Samadi","year":"2021","unstructured":"Samadi M, Aziz SG, Naderi R. The effect of tropisetron on oxidative stress, SIRT1, FOXO3a, and claudin-1 in the renal tissue of STZ-induced diabetic rats. Cell Stress Chaperones. 2021;26(1):217\u201327. https:\/\/doi.org\/10.1007\/s12192-020-01170-5.","journal-title":"Cell Stress Chaperones"},{"issue":"7","key":"1238_CR50","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s10157-024-02502-w","volume":"28","author":"K Hasegawa","year":"2024","unstructured":"Hasegawa K, Tamaki M, Shibata E, Inagaki T, Minato M, Yamaguchi S, et al. Ability of NAD and Sirt1 to epigenetically suppress albuminuria. Clin Exp Nephrol. 2024;28(7):599\u2013607. https:\/\/doi.org\/10.1007\/s10157-024-02502-w.","journal-title":"Clin Exp Nephrol"},{"issue":"17","key":"1238_CR51","doi-asserted-by":"publisher","first-page":"9641","DOI":"10.3390\/ijms22179641","volume":"22","author":"A Zaky","year":"2021","unstructured":"Zaky A, Glastras SJ, Wong MYW, Pollock CA, Saad S. The role of the gut microbiome in diabetes and obesity-related kidney disease. Int J Mol Sci. 2021;22(17):9641. https:\/\/doi.org\/10.3390\/ijms22179641.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1238_CR52","doi-asserted-by":"publisher","first-page":"6356","DOI":"10.1038\/s41467-022-33656-4","volume":"13","author":"X Yuan","year":"2022","unstructured":"Yuan X, Wang R, Han B, Sun C, Chen R, Wei H, et al. Functional and metabolic alterations of gut microbiota in children with new-onset type 1 diabetes. Nat Commun. 2022;13(1):6356. https:\/\/doi.org\/10.1038\/s41467-022-33656-4.","journal-title":"Nat Commun"},{"key":"1238_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116033","volume":"170","author":"SJ Zheng","year":"2024","unstructured":"Zheng SJ, Luo Y, Wang JB, Chen XM, Xu Y, Xiao JH. Regulated intestinal microbiota and gut immunity to ameliorate type 1 diabetes mellitus: a novel mechanism for stem cell-based therapy. Biomed Pharmacother. 2024;170:116033. https:\/\/doi.org\/10.1016\/j.biopha.2023.116033.","journal-title":"Biomed Pharmacother"},{"key":"1238_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2025.117065","volume":"265","author":"P Jin","year":"2025","unstructured":"Jin P, Peng XH, Zhang Y, Jiang H, Zhao YL, Du Y, et al. Integrating 16S rDNA sequencing analysis and targeted tryptophan metabolomics to reveal potential mechanism of mulberry leaf extract in treating type 2 diabetes mellitus mice. J Pharm Biomed Anal. 2025;265:117065. https:\/\/doi.org\/10.1016\/j.jpba.2025.117065.","journal-title":"J Pharm Biomed Anal"},{"key":"1238_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119417","volume":"342","author":"B Lin","year":"2025","unstructured":"Lin B, Bai G, Zhang Y, Wang Y, Chen S. Betulinic acid from Inonotus obliquus ameliorates T2DM by modulating short-chain fatty acids producing bacteria and amino acids metabolism in db\/db mice. J Ethnopharmacol. 2025;342:119417. https:\/\/doi.org\/10.1016\/j.jep.2025.119417.","journal-title":"J Ethnopharmacol"},{"key":"1238_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/nu17142363","author":"H Gong","year":"2025","unstructured":"Gong H, Zuo H, Wu K, Gao X, Lan Y, Zhao L. Systemic and retinal protective effects of butyrate in early type 2 diabetes via gut microbiota-lipid metabolism interaction. Nutrients. 2025. https:\/\/doi.org\/10.3390\/nu17142363.","journal-title":"Nutrients"},{"key":"1238_CR57","doi-asserted-by":"publisher","unstructured":"Salman U, Dabdoub SM, Reyes A, Sidahmed A, Weber-Gasperoni K, Brown R, et al. Dysbiotic microbiome-metabolome axis in childhood obesity and metabolic syndrome. J Dent Res. 2025, https:\/\/doi.org\/10.1177\/00220345251336129","DOI":"10.1177\/00220345251336129"},{"issue":"5","key":"1238_CR58","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s11427-023-2353-0","volume":"67","author":"W Jia","year":"2024","unstructured":"Jia W, Li Y, Cheung KCP, Zheng X. Bile acid signaling in the regulation of whole body metabolic and immunological homeostasis. Sci China Life Sci. 2024;67(5):865\u201378. https:\/\/doi.org\/10.1007\/s11427-023-2353-0.","journal-title":"Sci China Life Sci"},{"issue":"1","key":"1238_CR59","doi-asserted-by":"publisher","first-page":"2192155","DOI":"10.1080\/19490976.2023.2192155","volume":"15","author":"B Chen","year":"2023","unstructured":"Chen B, Bai Y, Tong F, Yan J, Zhang R, Zhong Y, et al. Glycoursodeoxycholic acid regulates bile acids level and alters gut microbiota and glycolipid metabolism to attenuate diabetes. Gut Microbes. 2023;15(1):2192155. https:\/\/doi.org\/10.1080\/19490976.2023.2192155.","journal-title":"Gut Microbes"},{"issue":"3","key":"1238_CR60","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.apsb.2022.10.011","volume":"13","author":"X Wei","year":"2023","unstructured":"Wei X, Yin F, Wu M, Xie Q, Zhao X, Zhu C, et al. G protein-coupled receptor 35 attenuates nonalcoholic steatohepatitis by reprogramming cholesterol homeostasis in hepatocytes. Acta Pharm Sin B. 2023;13(3):1128\u201344. https:\/\/doi.org\/10.1016\/j.apsb.2022.10.011.","journal-title":"Acta Pharm Sin B"},{"issue":"3","key":"1238_CR61","doi-asserted-by":"publisher","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","volume":"318","author":"JYL Chiang","year":"2020","unstructured":"Chiang JYL, Ferrell JM. Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy. Am J Physiol Gastrointest Liver Physiol. 2020;318(3):G554-g573. https:\/\/doi.org\/10.1152\/ajpgi.00223.2019.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"3","key":"1238_CR62","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1017\/s0029665116002834","volume":"76","author":"MS Trabelsi","year":"2017","unstructured":"Trabelsi MS, Lestavel S, Staels B, Collet X. Intestinal bile acid receptors are key regulators of glucose homeostasis. Proc Nutr Soc. 2017;76(3):192\u2013202. https:\/\/doi.org\/10.1017\/s0029665116002834.","journal-title":"Proc Nutr Soc"},{"key":"1238_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.890277","volume":"9","author":"J Shen","year":"2022","unstructured":"Shen J, Zhang L, Wang Y, Chen Z, Ma J, Fang X, et al. Beneficial actions of essential fatty acids in streptozotocin-induced type 1 Diabetes mellitus. Front Nutr. 2022;9:890277. https:\/\/doi.org\/10.3389\/fnut.2022.890277.","journal-title":"Front Nutr"},{"key":"1238_CR64","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.5c03515","author":"M Li","year":"2025","unstructured":"Li M, Guo J, Meng J, Wang X, Pan T, Zhao D, et al. Synbiotic intervention with inulin and lactiplantibacillus plantarum LPm77 attenuates type 2 diabetes via enhanced TUDCA metabolism and gut-liver axis modulation. J Agric Food Chem. 2025. https:\/\/doi.org\/10.1021\/acs.jafc.5c03515.","journal-title":"J Agric Food Chem"},{"issue":"12","key":"1238_CR65","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1111\/1753-0407.12956","volume":"11","author":"W Li","year":"2019","unstructured":"Li W, Liu R, Li X, Tao B, Zhai N, Wang X, et al. Saxagliptin alters bile acid profiles and yields metabolic benefits in drug-na\u00efve overweight or obese type 2 diabetes patient. J Diabetes. 2019;11(12):982\u201392. https:\/\/doi.org\/10.1111\/1753-0407.12956.","journal-title":"J Diabetes"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01238-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-025-01238-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01238-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:20:41Z","timestamp":1761816041000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-025-01238-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1238"],"URL":"https:\/\/doi.org\/10.1186\/s13020-025-01238-3","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiment was approved by the Animal Ethics Committee of Changchun University of Chinese Medicine and Institutional Animal Care (Approval No. 2024250).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors confirm their consent for publication the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"183"}}